Mark K Slifka Selected Research

Mark K Slifka Research Topics

Disease

32	Infections 01/2022 - 05/2002
12	Virus Diseases (Viral Diseases) 01/2022 - 02/2003
10	Smallpox (Variola) 11/2012 - 09/2003
9	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2005
6	Vaccinia 01/2022 - 06/2006
5	COVID-19 01/2022 - 01/2021
5	Yellow Fever 12/2020 - 07/2008
5	Diphtheria 05/2016 - 01/2005
5	Tetanus 05/2016 - 12/2006
4	Atopic Dermatitis (Atopic Eczema) 01/2022 - 07/2011
4	Viremia 04/2017 - 01/2013
4	Measles 11/2012 - 01/2005
3	West Nile Fever 01/2019 - 02/2013
3	Mumps 11/2012 - 01/2005
3	Rubella (German Measles) 11/2012 - 01/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2022
2	HIV Infections (HIV Infection) 01/2020 - 01/2016
2	Human Influenza (Influenza) 01/2019 - 01/2006
2	Dengue (Dengue Fever) 11/2018 - 01/2014
2	Persistent Infection 04/2017 - 10/2016
2	Poliomyelitis (Polio) 12/2016 - 01/2005
2	Whooping Cough (Pertussis) 11/2012 - 01/2005
2	Mpox (monkeypox) 05/2012 - 09/2005
2	Latent Infection 03/2011 - 05/2002
1	Atrophy 11/2022
1	Arthralgia (Joint Pain) 01/2022
1	Asthma (Bronchial Asthma) 12/2021
1	Diarrhea 01/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Malaria 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Mosquito-Borne Diseases 01/2019
1	Poxviridae Infections 10/2016
1	Lymphopenia (Lymphocytopenia) 01/2014
1	Disease Progression 01/2014
1	Coinfection 12/2012
1	Severe Dengue 10/2011
1	Weight Loss (Weight Reduction) 10/2011
1	Zoonoses 11/2009

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 01/2021 - 05/2002
16	Antiviral Agents (Antivirals)IBA 03/2021 - 09/2003
8	CytokinesIBA 08/2015 - 06/2004
7	AntigensIBA 01/2020 - 12/2006
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2003
5	Neutralizing AntibodiesIBA 01/2020 - 12/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 09/2021
3	AntibodiesIBA 01/2020 - 12/2005
3	Peptides (Polypeptides)IBA 05/2012 - 08/2009
3	EpitopesIBA 07/2004 - 05/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
2	Immunoglobulin G (IgG)IBA 04/2017 - 11/2012
2	Immunoglobulins (Immunoglobulin)IBA 10/2016 - 12/2005
2	PerforinIBA 01/2016 - 01/2010
2	Attenuated VaccinesIBA 05/2014 - 01/2014
2	Subunit VaccinesIBA 05/2014 - 01/2014
2	Viral AntigensIBA 01/2014 - 11/2007
2	Interleukin-12 (IL 12)IBA 01/2013 - 12/2004
2	Interleukin-18 (Interleukin 18)IBA 01/2013 - 12/2004
2	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 06/2006 - 01/2005
1	Tryptophan (L-Tryptophan)FDA Link 11/2022
1	CeramidesIBA 01/2022
1	Filaggrin ProteinsIBA 01/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022
1	SphingolipidsIBA 01/2022
1	Explosive Agents (Explosives)IBA 01/2022
1	mRNA VaccinesIBA 09/2021
1	Ad26COVS1IBA 09/2021
1	Indicators and Reagents (Reagents)IBA 03/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2020
1	Detergents (Detergent)IBA 01/2019
1	Hemagglutinins (Hemagglutinin)IBA 01/2019
1	Dengue VaccinesIBA 11/2018
1	GP 140IBA 04/2017
1	Immunoglobulin IsotypesIBA 04/2017
1	Rotavirus VaccinesIBA 12/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2016
1	Ethanol (Ethyl Alcohol)IBA 10/2016
1	LigandsIBA 08/2015
1	Immunoglobulin E (IgE)IBA 02/2014
1	EnzymesIBA 01/2014
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2013
1	Bacterial ToxinsIBA 11/2012
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2012
1	Small Interfering RNA (siRNA)IBA 10/2011
1	Claudin-1IBA 07/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2011
1	Granzymes (Granzyme)IBA 01/2010
1	Povidone-Iodine (Betadine)FDA LinkGeneric 01/2008
1	Ointments (Pastes)IBA 01/2008
1	Bromodeoxyuridine (BrdU)IBA 05/2007
1	Hepatitis B e AntigensIBA 12/2006
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 06/2006
1	Immunoglobulin A (IgA)IBA 12/2005

Therapy/Procedure

4	Therapeutics 01/2020 - 06/2004
1	Precision Medicine 12/2021
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2020
1	Stem Cell Transplantation 01/2020